Crossmark

Alemtuzumab and autoimmune polyglandular syndrome with type 1 diabetes mellitus

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2024.02.006

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García Estévez, D.A.

Pinal Osorio, I.

Pato Pato, A.
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2024-02-20
More Information

This article is maintained by: Elsevier

Article Title: Alemtuzumab and autoimmune polyglandular syndrome with type 1 diabetes mellitus

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2024.02.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2023.07.001

Content Type: simple-article

Copyright: © 2024 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.